The WISDOM study—Women Informed to Screen Depending On Measures of risk—was launched to test a personalized approach to screening compared to annual mammograms. Funmi Olopade, MD, FACP, is a professor of Medicine and Human Genetics and founding director of the Center for Clinical Cancer Genetics and Global Health at the University of Chicago Medical Center, and a co-investigator of WISDOM. She discussed how the COVID-19 pandemic actually helped increase participation in the WISDOM study and what it means for future trials.
How has the COVID-19 pandemic impacted the WISDOM study, both in participation rates and results?
The way it has impacted us, of course, was that we shut down for several months not able to work. I was over the age of 60, and the only thing I could do was to do video consultation with my patients. But what's been really remarkable is we also learned that that's probably the best way to reach those that we thought we couldn't reach, because it then made it convenient for women to sit in their home, to fill out a questionnaire, to then have kits sent to them because we’re doing the tests with saliva kits. While women were sitting at home, we got more participation of our breast cancer advocates and our breast cancer patients in survey questions. We also realized that COVID was all about testing, testing, testing.
The University of Chicago was one of the earliest centers to actually take testing into the community. We collaborated with the South Side Health Collaborative and South Side Health Care providers to provide testing in the community. And as a result of that, anyone who got tested and was positive for COVID, they got early access to clinical trials that we were doing at the University of Chicago, because it was now no longer about whether you had insurance or not. And we saved a lot of lives. Chicago now has a Chicago health equity initiative, because all of the academic centers now realized that you can't sit there and expect patients to come to you when they have no insurance.
So yes, it impacted us. But we're hoping that we can use the foundation work that we built during the pandemic to reach more women who otherwise would not have been able to participate. And that after the pandemic, we would be able to—it doesn't matter whether you're in rural America, urban America, a low resource setting—everyone will have a chance to participate in life-saving clinical trials.
When we're looking at how COVID has impacted us, I think those who were not able to get screened, now if we identify them as the highest risk patients, they're going to be the first in line. And they have been the first in line to come in and get their mammogram, get their MRI. And I think testing and COVID hopefully will teach us how to organize health systems so that it works for the patient, not for us, right? It has to be patient centered.
So I think we will learn something. And using the platform of these clinical trials that were done during COVID to get people vaccinated, we hope will help us to improve the rates of participation in WISDOM by all patients, not just those who have the convenience of having Internet access in their offices.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More
Dr Al Benson on Reimbursement for Supportive Care When Treating Patients With Cancer
March 22nd 2024Al Benson, MD, FACP, FACCC, FASCO, medical oncologist at Northwestern University Feinberg School of Medicine and associate director of the Robert E. Tillery Comprehensive Cancer Center, discussed findings from a national survey assessing barriers to comprehensive cancer care delivery.
Read More